SCHEMBL22356325

SCHEMBL22356325

C=CC(=O)Oc1ccc(Nc2nc(Nc3ccc(OC(=O)C=C)cc3)nc(Nc3ccc(OC(=O)C=C)cc3)n2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.49
FLT3 P36888 1/20 0.49
BLK P51451 1/20 0.49
THRB P10828 2/20 0.46
MAPT P10636 5/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
GAA P10253 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
POLB P06746 1/20 0.41
ALDH1A1 P00352 2/20 0.41
HSP90AA1 P07900 1/20 0.41
KCNH3 Q9ULD8 1/20 0.41
TGM2 P21980 2/20 0.40
PIN1 Q13526 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22356450 0.94 MAPT (0.51) EGFRFLT3BLKTHRBMAPT
SCHEMBL22356446 0.94 MAPT (0.51) EGFRFLT3BLKTHRBMAPT
SCHEMBL22356458 0.94 EGFR (0.46) EGFRFLT3BLKTHRBMAPT
SCHEMBL22356459 0.94 EGFR (0.46) EGFRFLT3BLKTHRBMAPT
SCHEMBL22356482 0.94 MAPT (0.51) EGFRFLT3BLKTHRBMAPT
SCHEMBL22356481 0.94 MAPT (0.51) EGFRFLT3BLKTHRBMAPT
SCHEMBL22356392 0.91 RHOA (0.49) EGFRFLT3BLK
SCHEMBL22356381 0.90 RHOA (0.51) EGFRFLT3BLKMAPTMEN1
SCHEMBL22356433 0.89 RHOA (0.54) EGFRFLT3BLKMAPTMEN1
SCHEMBL22356391 0.89 RHOA (0.54) EGFRFLT3BLKMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200262798-A1 NOVEL TRIAZINE DERIVATIVE AND PHOTOSENSITIVE COMPOSITION COMPRISING SAME TREEEL CO., LTD (KR) 2020-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200262798-A1 NOVEL TRIAZINE DERIVATIVE AND PHOTOSENSITIVE COMPOSITION COMPRISING SAME TYR, CRY2, CRY1 EGFR 2575/4885FLT3 345/4885BLK 2717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.